| |||||||
| |||||||
| |||||||
1 | SENATE RESOLUTION
| ||||||
2 | WHEREAS, Rare diseases and disorders are those which affect | ||||||
3 | small patient populations, typically populations smaller than | ||||||
4 | 200,000 individuals in the United States; and
| ||||||
5 | WHEREAS, Nearly 7,000 rare diseases affect millions of | ||||||
6 | Americans and their families; and
| ||||||
7 | WHEREAS, Children with rare genetic diseases account for | ||||||
8 | more than half of the population affected by rare diseases in | ||||||
9 | the United States; and
| ||||||
10 | WHEREAS, Many rare diseases are serious, life-threatening, | ||||||
11 | and lack an effective treatment; and
| ||||||
12 | WHEREAS, Rare diseases and conditions include | ||||||
13 | epidermolysis bullosa, progeria, sickle cell anemia, | ||||||
14 | Tay-Sachs, cystic fibrosis, many childhood cancers, | ||||||
15 | fibrodysplasia ossificans progressiva, and Williams Syndrome; | ||||||
16 | and
| ||||||
17 | WHEREAS, People with rare diseases experience challenges | ||||||
18 | that include difficulty in obtaining an accurate diagnosis, | ||||||
19 | limited treatment options, and difficulty finding physicians | ||||||
20 | or treatment centers with expertise in their disease; and |
| |||||||
| |||||||
1 | WHEREAS, Great strides have been made in research and | ||||||
2 | treatment for rare diseases as a result of the Orphan Drug Act | ||||||
3 | and other acts of Congress; and
| ||||||
4 | WHEREAS, The United States Food and Drug Administration and | ||||||
5 | National Institutes of Health have established special offices | ||||||
6 | to advocate for rare disease research and treatments; and | ||||||
7 | WHEREAS, The National Organization for Rare Disorders, an | ||||||
8 | organization established in 1983 to provide services to, and | ||||||
9 | advocate on behalf of, patients with rare diseases, was a | ||||||
10 | primary force behind the enactment of the Orphan Drug Act and | ||||||
11 | remains a critical public voice for people with rare diseases; | ||||||
12 | and | ||||||
13 | WHEREAS, The National Organization for Rare Disorders | ||||||
14 | sponsors Rare Disease Day nationwide to increase public | ||||||
15 | awareness of rare diseases; and | ||||||
16 | WHEREAS, Rare Disease Day has become a global event | ||||||
17 | occurring annually on the last day of February; and | ||||||
18 | WHEREAS, Rare Disease Day was observed in the United States | ||||||
19 | for the first time on February 28, 2009; and |
| |||||||
| |||||||
1 | WHEREAS, Rare Disease Day is anticipated to be observed | ||||||
2 | globally in years to come, providing hope and information for | ||||||
3 | rare disease patients around the world; and | ||||||
4 | WHEREAS, It is fitting that the Illinois Senate joins in | ||||||
5 | this global observance and takes part in the fight against rare | ||||||
6 | diseases; therefore, be it
| ||||||
7 | RESOLVED, BY THE SENATE OF THE NINETY-EIGHTH GENERAL | ||||||
8 | ASSEMBLY OF THE STATE OF ILLINOIS, that we designate the last | ||||||
9 | day of February in 2013 and 2014 as Rare Disease Day in the | ||||||
10 | State of Illinois; and be it further
| ||||||
11 | RESOLVED, That we recognize the importance of improving | ||||||
12 | awareness and encouraging accurate and early diagnosis of rare | ||||||
13 | diseases and disorders; and be it further | ||||||
14 | RESOLVED, That we wholeheartedly support a State, | ||||||
15 | national, and global commitment to improving access to and | ||||||
16 | developing new treatments, diagnostics, and cures for rare | ||||||
17 | diseases and disorders.
|